{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:15:36Z","timestamp":1758125736558},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.remn.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,12,5]],"date-time":"2015-12-05T01:53:39Z","timestamp":1449280419000},"page":"171-174","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of 11C-PIB cerebral retention in mild cognitive impairment patients"],"prefix":"10.1016","volume":"35","author":[{"given":"I.","family":"Banzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Jim\u00e9nez-Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Arcocha-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Bravo-Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lavado-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e1nchez-Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jim\u00e9nez-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"L\u00f3pez-Defill\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Carril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2015.09.008_bib0150","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.remn.2015.09.008_bib0155","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.remn.2015.09.008_bib0160","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.remn.2015.09.008_bib0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.remn.2015.09.008_bib0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MNM.0000000000000042","article-title":"Amyloid imaging with (11)C-PIB PET\/CT and glucose metabolism with (18)F-FDG PET\/CT in a study on cognitive impairment in the clinical setting","volume":"35","author":"Banzo","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2015.09.008_bib0175","article-title":"Amyloid imaging with 11C-PIB in patients with cognitive impairment in a clinical setting. A visual and semiquantitative analysis","author":"Jim\u00e9nez-Bonilla","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remn.2015.09.008_bib0180","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.110.076315","article-title":"Brain amyloid imaging","volume":"52","author":"Rowe","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.09.008_bib0185","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2967\/jnumed.114.141416","article-title":"Multimodality imaging of Alzheimer disease and other neurodegenerative dementias","volume":"55","author":"Nasrallah","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.09.008_bib0190","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0000000000000032","article-title":"Practical utility of amyloid and FDG-PET in an academic dementia center","volume":"82","author":"S\u00e1nchez-Juan","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.remn.2015.09.008_bib0195","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.remn.2015.09.008_bib0200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21598","article-title":"Amyloid imaging in mild cognitive impairment subtypes","volume":"65","author":"Wolk","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.remn.2015.09.008_bib0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease and Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.remn.2015.09.008_bib0210","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.jalz.2013.06.001","article-title":"Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid imaging task force of the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.remn.2015.09.008_bib0215","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.remn.2015.09.008_bib0220","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000260969.94695.56","article-title":"PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment","volume":"68","author":"Kemppainen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.remn.2015.09.008_bib0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000163927","article-title":"PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment","volume":"26","author":"Koivunen","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.remn.2015.09.008_bib0230","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.remn.2015.09.008_bib0235","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.remn.2015.09.008_bib0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/01.wnl.0000228244.10416.20","article-title":"Mild cognitive impairment risk of Alzheimer disease and rate of cognitive decline","volume":"67","author":"Boyle","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.remn.2015.09.008_bib0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamapsychiatry.2013.4506","article-title":"Synergistic effects of ischemia and \u03b2-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment","volume":"71","author":"Lee","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.remn.2015.09.008_bib0250","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2967\/jnumed.108.058529","article-title":"Comparison of 18F-FDG and PIB-PET in cognitive impairment","volume":"50","author":"Lowe","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.09.008_bib0255","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0891988710363715","article-title":"Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, mild cognitive impairment, and healthy controls","volume":"23","author":"Devanand","year":"2010","journal-title":"J Geriartr Psychiatry Neurol"},{"key":"10.1016\/j.remn.2015.09.008_bib0260","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuroimage.2008.07.053","article-title":"Apperance modeling of 11C PIB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging","volume":"43","author":"Fripp","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.remn.2015.09.008_bib0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","article-title":"Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease","volume":"48","author":"Ng","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2015.09.008_bib0270","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2015.09.008_bib0275","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","article-title":"Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease","volume":"39","author":"Drzezga","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.remn.2015.09.008_bib0280","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.neurobiolaging.2008.01.016","article-title":"Clinical severity of Alzheimer's disease is associated with PIB uptake in PET","volume":"30","author":"Grimmer","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.remn.2015.09.008_bib0285","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.remn.2015.09.008_bib0290","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X15001365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X15001365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T11:07:21Z","timestamp":1653736041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X15001365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2253654X15001365"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2015.09.008","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of 11C-PIB cerebral retention in mild cognitive impairment patients","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}